References
- Ammann P, Rizzoli R. (2003). Bone strength and its determinants. Osteoporos Int 14:S13–S18.
- Aukrust P, Yndestad A, Smith C, et al. (2005). Potential role for immunomodulatory therapy in atherosclerotic plaque stabilisation. Expert Opin Pharmacother 6:2169–80.
- Chan WW, Wong GT, Irwin MG. (2013). Perioperative statin therapy. Expert Opin Pharmacother 14:831–42.
- Chuengsamarn S, Rattanamongkoulgul S, Suwanwalaikorn S, et al. (2010). Effects of statins vs. non-statin lipidlowering therapy on bone formation and bone mineral density biomarkers in patients with hyperlipidemia. Bone 46:1011–15.
- Chunjian Z. (2012). Determination of Atorvastatin in Human Plasma by HPLC and Pharmacokinetics Study. China Pharmacy 23:2833–5.
- Davignon J, Mabile L. (2001). Mechanisms of action of statins and their pleiotropic effects. Ann Endocrinol (Paris) 62:101–12.
- Du YZ, Weng Q, Yuan H, et al. (2010). Synthesis and antitumor activity of stearate-g-dextran micelles for intracellular doxorubicin delivery. ACS Nano 4:6894–902.
- Esposito K, Capuano A, Sportiello L, et al. (2013). Should we abandon statins in the prevention of bone fractures? Endocrine 44:326–33.
- Hamrick I, Schrager S, Nye AM. (2015). Treatment of osteoporosis: current state of the art. Wien Med Wochenschr 165:54–64.
- Johnell O, Kanis JA. (2004). An estimate of the worldwide prevalence, mortality and disability associated with hip fracture. Osteoporos Int 15:897–902.
- Lips P, Jameson K, Bianchi ML, et al. (2009). Working group for quality of life of the international osteoporosis foundation. Osteoporos Int 21:61–70.
- Luhmann T, Germershaus O, Groll J, et al. (2012). Bone targeting for the treatment of osteoporosis. J Control Release 161:198–213.
- Moshiri A, Oryan A, Meimandi-Parizi A,et al. (2014). Effectiveness of xenogenous-based bovine-derived platelet gel embedded within a threedimensional collagen implant on the healing and regeneration of the Achilles tendon defect in rabbits. Expert Opin Biol Ther 14:1065–89.
- Nicolas J, Mura S, Brambilla D, et al. (2013). Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery. Chem Soc Rev 42:1147–235.
- Oryan A, Alidadi S, Moshiri A, et al. (2014). Bone regenerative medicine: classic options, novel strategies, and future directions. J Orthop Surg Res 9:18–25.
- Oryan A, Moshiri A, Meimandi Parizi A. (2012). Alcoholic extract of Tarantula cubensis improves sharp ruptured tendon healing after primary repair in rabbits. Am J Orthop 41:554–60.
- Patel J, Martin SS, Banach M. (2016). Expert opinion: the therapeutic challenges faced by statin intolerance. Expert Opin Pharmacother 17:1497–507.
- Perrin DD. (1965). Binding of tetracyclines to bone. Nature 208:787–8.
- Ryu TK, Kang RH, Jeong KY, et al. (2016). Bone-targeted delivery of nanodiamond-based drug carriers conjugated with alendronate for potential osteoporosis treatment. J Control Release 232:152–60.
- Shirke SS, Jadhav SR, Jagtap AG. (2008). Methanolic extract of Cuminum cyminum inhibits ovariectomy-induced bone loss in rats. Exp Biol Med (Maywood) 233:1403–10.
- Shuid AN, Ibrahim N, Mohd Amin MC, et al. (2013). Drug delivery systems for prevention and treatment of osteoporotic fracture. Curr Drug Targets 14:1558–64.
- Wang CZ, Fu YC, Jian SC, et al. (2014). Synthesis and characterization of cationic polymeric nanoparticles as simvastatin carriers for enhancing the osteogenesis of bone marrow mesenchymal stem cells. J Colloid Interface Sci 432:190–9.